Javascript must be enabled to continue!
Simultaneous solubilization of high‐affinity receptors for VIP and glucagon and of a low‐affinity binding protein for VIP, shown to be identical to calmodulin
View through CrossRef
Anion‐exchange chromatography of solubilized pig liver cell membranes on DEAE‐Sepharose gave a fraction with high affinity binding proteins for VIP and glucagon distinct from each other. Scatchard analysis indicated the presence of one binding site for VIP (K
d 1.5 ± 0.6 nM and B
max 1.3 ± 0.4 pmol/mg). The order of potency for VIP‐related peptides to inhibit [125I]VIP binding was: VIP > peptide histidine isoleucine amide (PHI) > rat growth hormone releasing factor (rGRF) > secretin. GTP‐γ‐S inhibited [125I]vip binding and reduced the affinity of VIP binding sites to 6.5 nM. In the same isolated fraction, [125I]glucagon binding was displaced by glucagon preferentially to oxyntomodulin, and GTP did not affect this [125I]glucagon binding. Scatchard analysis indicated the presence of one binding site for glucagon (K
d 0.08 ± 0.03 nM and B
max 0.31 ± 0.01 pmol/lg). A low‐affinity VIP binding protein (IC50 0.7 μM) was detected in a fraction eluting later and exhibited a peptide specificity: rGRF > VIP > VIP(10–28) > secretin > PHI. This rGRF‐preferring protein (18 kDa) was purified and had a partial amino‐acid sequence identical to that of calmodulin. Its [125I]VIP binding was competitively inhibited by VIP and calmidazolium in a manner similar to that for pig brain calmodulin. Thus we have co‐solubilized VIP and glucagon high affinity receptors from pig liver cell membranes and separated them from VIP‐binding calmodulin.
Title: Simultaneous solubilization of high‐affinity receptors for VIP and glucagon and of a low‐affinity binding protein for VIP, shown to be identical to calmodulin
Description:
Anion‐exchange chromatography of solubilized pig liver cell membranes on DEAE‐Sepharose gave a fraction with high affinity binding proteins for VIP and glucagon distinct from each other.
Scatchard analysis indicated the presence of one binding site for VIP (K
d 1.
5 ± 0.
6 nM and B
max 1.
3 ± 0.
4 pmol/mg).
The order of potency for VIP‐related peptides to inhibit [125I]VIP binding was: VIP > peptide histidine isoleucine amide (PHI) > rat growth hormone releasing factor (rGRF) > secretin.
GTP‐γ‐S inhibited [125I]vip binding and reduced the affinity of VIP binding sites to 6.
5 nM.
In the same isolated fraction, [125I]glucagon binding was displaced by glucagon preferentially to oxyntomodulin, and GTP did not affect this [125I]glucagon binding.
Scatchard analysis indicated the presence of one binding site for glucagon (K
d 0.
08 ± 0.
03 nM and B
max 0.
31 ± 0.
01 pmol/lg).
A low‐affinity VIP binding protein (IC50 0.
7 μM) was detected in a fraction eluting later and exhibited a peptide specificity: rGRF > VIP > VIP(10–28) > secretin > PHI.
This rGRF‐preferring protein (18 kDa) was purified and had a partial amino‐acid sequence identical to that of calmodulin.
Its [125I]VIP binding was competitively inhibited by VIP and calmidazolium in a manner similar to that for pig brain calmodulin.
Thus we have co‐solubilized VIP and glucagon high affinity receptors from pig liver cell membranes and separated them from VIP‐binding calmodulin.
Related Results
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Postprandial Glucagon Action in the Human Brain
Postprandial Glucagon Action in the Human Brain
ABSTRACT
Aims
Elevated fasting glucagon is linked to hyperglycemia, but postprandial glucagon effects are less understood...
Glucagon and Its Receptors in the Mammalian Heart
Glucagon and Its Receptors in the Mammalian Heart
Glucagon exerts effects on the mammalian heart. These effects include alterations in the force of contraction, beating rate, and changes in the cardiac conduction system axis. The ...
Calmodulin-binding proteins in bovine semen
Calmodulin-binding proteins in bovine semen
An 125I-labelled calmodulin gel overlay procedure was used to direct calmodulin-binding proteins in bovine spermatozoa and seminal plasma. Several calmodulin-binding proteins with ...
Tat peptide‐calmodulin binding studies and bioinformatics of HIV‐1 protein–calmodulin interactions
Tat peptide‐calmodulin binding studies and bioinformatics of HIV‐1 protein–calmodulin interactions
AbstractThe human immunodeficiency virus type 1 (HIV‐1) genome encodes 18 proteins and 2 peptides. Four of these proteins encode high‐affinity calmodulin‐binding sites for which di...
Functional, genetic and bioinformatic characterization of a calcium/calmodulin kinase gene in Sporothrix schenckii
Functional, genetic and bioinformatic characterization of a calcium/calmodulin kinase gene in Sporothrix schenckii
Abstract
Background
Sporothrix schenckii is a pathogenic, dimorphic fungus, the etiological agent of sporotrichosis, a subcutaneou...
34-OR: Postprandial Glucagon Action in the Human Brain
34-OR: Postprandial Glucagon Action in the Human Brain
While elevated fasting glucagon is linked to hyperglycemia, the impact of postprandial changes in glucagon is less clear. Recent findings suggest potential metabolic benefits of ri...
Temporal relation of calcium-calmodulin binding and neuronal damage after global ischemia in rats.
Temporal relation of calcium-calmodulin binding and neuronal damage after global ischemia in rats.
This study explores the temporal relation of the severity of ischemia and calcium-calmodulin binding in vulnerable and resistant brain regions in a commonly used model of global is...

